Gregory Alan Korbel - SVP, Chief Operating Officer at Aprea Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
SVP, Chief Operating Officer
Issuer Symbol
APRE on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Gregory Alan Korbel since 10 Mar 2025

Holdings reported by Gregory Alan Korbel for Aprea Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 45,762 $168,445 $3.68 28 Jul 2022 Direct
Stock Option (right to Buy) 35,700 28 Jul 2022 Direct Common Stock

Transactions reported by Gregory Alan Korbel for Aprea Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.